Smith, Salley & Associates Elanco Animal Health Inc Transaction History

Smith, Salley & Associates

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$8.79 - $14.58 $10,565 - $17,525	1,202 Added 4.27%	29,374 $276,000
Q4 2022 Feb 03, 2023	SELL	$11.49 - $13.65 $7,215 - $8,572	-628 Reduced 2.18%	28,172 $344,000
Q3 2022 Nov 01, 2022	BUY	$12.41 - $32.42 $27,227 - $71,129	2,194 Added 8.25%	28,800 $357,000
Q2 2022 Aug 01, 2022	SELL	$19.63 - $26.62 $7,537 - $10,222	-384 Reduced 1.42%	26,606 $522,000
Q1 2022 May 10, 2022	SELL	$24.65 - $29.0 $517 - $609	-21 Reduced 0.08%	26,990 $704,000
Q4 2021 Feb 10, 2022	BUY	$27.74 - $34.09 $45,049 - $55,362	1,624 Added 6.4%	27,011 $767,000
Q3 2021 Nov 05, 2021	BUY	$29.2 - $36.72 $60,706 - $76,340	2,079 Added 8.92%	25,387 $810,000
Q2 2021 Aug 09, 2021	BUY	$28.76 - $35.98 $73,654 - $92,144	2,561 Added 12.34%	23,308 $809,000
Q1 2021 Apr 30, 2021	BUY	$27.85 - $34.49 $19,355 - $23,970	695 Added 3.47%	20,747 $611,000
Q4 2020 Jan 28, 2021	BUY	$27.53 - $33.79 $114,497 - $140,532	4,159 Added 26.17%	20,052 $615,000
Q3 2020 Nov 05, 2020	BUY	$21.1 - $29.13 $116,028 - $160,185	5,499 Added 52.91%	15,893 $444,000
Q2 2020 Aug 04, 2020	BUY	$18.94 - $24.93 $26,667 - $35,101	1,408 Added 15.67%	10,394 $223,000
Q1 2020 Apr 24, 2020	BUY	$16.68 - $32.25 $20,866 - $40,344	1,251 Added 16.17%	8,986 $201,000
Q4 2019 Jan 27, 2020	BUY	$25.29 - $29.45 $195,618 - $227,795	7,735 New	7,735 $228,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

Stay updated on Smith, Salley & Associates with notifications on news.